AVPR2 and autosomal dominant polycystic kidney disease: While V2R, the molecular target of tolvaptan, is directly linked to PKD pathophysiology (Wang et al., 2008), the diffusion profile also describes the interaction of V2R with other first order ADPKD-associated proteins via additional entities or biological functions, adding more nuance to the drug-treatment picture.